---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-23-001033"
form_type: "8-K"
ticker: "PMDI"
cik: "0000806517"
company_name: "PSYCHEMEDICS CORP"
filed_at: "2023-02-16T23:59:59+00:00"
generated_at: "2026-06-19T09:57:08.817058+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Psychemedics approves 2023 cash bonus plans for executives

## Summary
- Compensation committee approved 2023 cash bonus arrangements for CEO, EVP, VP Lab Ops, and Controller.
- Participants (excluding EVP) can earn up to 25% of base salary based on revenue, earnings, and individual goals.
- EVP target is 20% base salary on revenue goal and 5% on earnings goal.
- Committee retains right to withdraw, amend, or terminate bonus arrangements at any time.
- Post-year-end CEO review will assess individual goal achievement for other participants.

## SEC filing metadata
- accession: 0001171843-23-001033
- form_type: 8-K
- ticker: PMDI
- cik: 0000806517
- company_name: PSYCHEMEDICS CORP
- filed_at: 2023-02-16T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/806517/000117184323001033/0001171843-23-001033-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/806517/000117184323001033/f8k_021623.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-23-001033
- JSON: https://secwatch.observer/filing/0001171843-23-001033.json
- Plain text: https://secwatch.observer/filing/0001171843-23-001033.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.